Advances in medical technologies and clinical practice book series,
Год журнала:
2024,
Номер
unknown, С. 123 - 166
Опубликована: Дек. 13, 2024
Pharmacogenomics,
the
study
of
how
genes
influence
an
individual's
response
to
drugs,
is
changing
scene
medication
disclosure
and
improvement
by
joining
pharmacology
genomics
make
powerful,
custom-made
hereditary
profile.
This
arising
field
vital
in
customized
medication,
where
medicines
are
upgraded
light
individual
varieties.
chapter
offers
in-depth
exploration
global
impact
pharmacogenomics,
underscoring
key
examination
foundations
undertakings,
moral
contemplations,
difficulties
future
headings.
The
joint
efforts
exhibit
capability
endeavor
defeat
advance
fitting
worldwide
guidelines
creating
strategies
that
help
even-handed
admittance
pharmacogenomic
progressions
significant
for
reconciliation
medication.
Abstract
Cell
death
regulation
is
essential
for
tissue
homeostasis
and
its
dysregulation
often
underlies
cancer
development.
Understanding
the
different
pathways
of
cell
can
provide
novel
therapeutic
strategies
battling
cancer.
This
review
explores
several
key
mechanisms
apoptosis,
necroptosis,
autophagic
death,
ferroptosis,
pyroptosis.
The
research
gap
addressed
involves
a
thorough
analysis
how
these
be
precisely
targeted
therapy,
considering
tumor
heterogeneity
adaptation.
It
delves
into
genetic
epigenetic
factors
signaling
cascades
like
phosphatidylinositol
3‐kinase/protein
kinase
B/mammalian
target
rapamycin
(PI3K/AKT/mTOR)
mitogen‐activated
protein
kinase/extracellular
signal‐regulated
(MAPK/ERK)
pathways,
which
are
critical
death.
Additionally,
interaction
microenvironment
with
cells,
particularly
influence
hypoxia,
nutrient
deprivation,
immune
cellular
interactions,
explored.
Emphasizing
strategies,
this
highlights
emerging
modulators
inducers
such
as
B
lymphoma
2
(BCL2)
homology
domain
3
(BH3)
mimetics,
tumour
necrosis
factor‐related
apoptosis‐inducing
ligand
(TRAIL),
chloroquine,
innovative
approaches
to
induce
ferroptosis
provides
insights
therapy's
future
direction,
focusing
on
multifaceted
circumvent
drug
resistance.
examination
evolving
underlines
considerable
clinical
potential
continuous
necessity
in‐depth
exploration
within
scientific
domain.
Molecular Aspects of Medicine,
Год журнала:
2025,
Номер
101, С. 101335 - 101335
Опубликована: Янв. 1, 2025
Renal
cell
carcinoma
(RCC)
is
a
malignant
tumor
with
highly
heterogeneous
and
complex
molecular
mechanisms.
Through
systematic
analysis
of
TCGA,
COSMIC
other
databases,
24
mutated
genes
closely
related
to
RCC
were
screened,
including
VHL,
PBRM1,
BAP1
SETD2,
which
play
key
roles
in
signaling
pathway
transduction,
chromatin
remodeling
DNA
repair.
The
PI3K/AKT/mTOR
particularly
important
the
pathogenesis
RCC.
Mutations
such
as
PIK3CA,
MTOR
PTEN
are
associated
metabolic
abnormalities
proliferation.
Clinically,
mTOR
inhibitors
VEGF-targeted
drugs
have
shown
significant
efficacy
personalized
therapy.
Abnormal
regulation
reprogramming,
especially
glycolysis
glutamine
pathways,
provides
cells
continuous
energy
supply
survival
advantages,
GLS1
promising
results
preclinical
studies.
This
paper
also
explores
potential
immune
checkpoint
combination
targeted
drugs,
well
application
nanotechnology
drug
delivery
In
addition,
unique
mechanisms
revealed
individualized
therapeutic
strategies
explored
for
specific
subtypes
TFE3,
TFEB
rearrangement
type
SDHB
mutant
type.
review
summarizes
common
gene
mutations
their
mechanisms,
emphasizes
diagnosis,
treatment
prognosis,
looks
forward
prospects
multi-pathway
therapy,
immunotherapy
treatment,
providing
theoretical
support
clinical
guidance
new
development.
Biosensors and Bioelectronics,
Год журнала:
2024,
Номер
258, С. 116340 - 116340
Опубликована: Апрель 25, 2024
The
escalating
global
incidence
of
infectious
diseases
caused
by
pathogenic
bacteria,
especially
in
developing
countries,
emphasises
the
urgent
need
for
rapid
and
portable
pathogen
detection
devices.
This
study
introduces
a
sensitive
specific
electrochemical
biosensing
platform
utilising
cost-effective
electrodes
fabricated
inkjet-printing
gold
silver
nanoparticles
on
plastic
substrate.
biosensor
exploits
CRISPR/Cas12a
system
detecting
DNA
sequence
selected
from
genome
target
pathogen.
Upon
detection,
trans-activity
Cas12a/gRNA
is
triggered,
leading
to
cleavage
rationally
designed
single-strand
reporters
(linear
hairpin)
labelled
with
methylene
blue
(ssDNA-MB)
bound
electrode
surface.
In
principle,
this
sensing
mechanism
can
be
adapted
any
bacterium
choosing
proper
guide
RNA
its
DNA.
biosensor's
performance
was
assessed
two
representative
pathogens
(a
Gram-negative,
Escherichia
coli,
Gram-positive,
Staphylococcus
aureus),
results
obtained
inkjet-printed
were
compared
those
commercial
screen-printed
electrodes.
Our
show
that
use
nanostructured
electrodes,
which
provide
large
surface
area,
combination
hairpin
containing
poly-T
loop
increase
sensitivity
assay
corresponding
signal
variation
86%.
targets
amplified
various
clinically
isolated
have
been
tested
demonstrate
potential
proposed
point-of-need
applications.
International Journal of Molecular Sciences,
Год журнала:
2025,
Номер
26(5), С. 2005 - 2005
Опубликована: Фев. 25, 2025
CRISPR-Cas
is
an
adaptive
immune
system
found
in
bacteria
and
archaea
that
provides
resistance
against
invading
nucleic
acids.
Elements
of
this
natural
have
been
harnessed
to
develop
several
genome
editing
tools,
including
CRISPR-Cas9.
This
technology
relies
on
the
ability
nuclease
Cas9
cut
DNA
at
specific
locations
directed
by
a
guide
RNA.
In
addition,
activity
requires
presence
short
nucleotide
motif
(5'-NGG-3'
for
from
Streptococcus
pyogenes)
called
PAM,
flanking
targeted
region.
As
reliance
PAM
typically
strict,
diverse
variants
recognising
different
motifs
studied
target
broader
range
genomic
sites.
study,
we
assessed
potential
mutans
strain
P42S
(SmutCas9)
gene
editing.
SmutCas9
recognises
rarely
5'-NAA-3'
5'-NGAA-3'
PAMs.
To
test
its
efficacy,
two
genes
virulent
lactococcal
phage
p2
were
edited,
thereby
demonstrating
purposes,
particularly
AT-rich
genomes.
Sequencing
total
RNA
also
revealed
components
system,
allowing
further
molecular
characterisation
type
II-A
S.
mutans.
Advanced Therapeutics,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 3, 2025
Abstract
The
rise
of
antibiotic‐resistant
bacteria,
driven
by
antibiotic
misuse,
is
a
major
global
health
threat.
Addressing
this
issue
requires
understanding
resistance
mechanisms
and
developing
innovative
solutions.
Clustered
Regularly
Interspaced
Short
Palindromic
Repeats
(CRISPR)‐associated
systems
(Cas),
genome‐editing
tool
derived
from
prokaryotic
defense
mechanisms,
offers
precise
targeting
genes.
By
reprogramming
CRISPR‐Cas,
bacteria
can
be
killed
or
resensitized
to
antibiotics
through
plasmid
curing.
However,
clinical
applications
face
challenges,
particularly
in
delivering
CRISPR‐Cas
components
effectively.
Nanotechnology
has
emerged
as
promising
approach
for
targeted
delivery
tissues
cells.
This
paper
explores
the
molecular
resistance,
emphasizing
structure
function
their
mechanisms.
It
highlights
use
nanoparticles
(NPs)
nanoscale
carriers
deliver
components,
reviewing
recent
studies
that
combine
NPs
CRISPR
target
Additionally,
discusses
current
challenges
future
prospects
field,
underscoring
potential
nanotechnology
combat
resistance.
Current Issues in Molecular Biology,
Год журнала:
2025,
Номер
47(4), С. 238 - 238
Опубликована: Март 29, 2025
The
blaOXA-1
gene
encodes
an
oxacillin-hydrolyzing
beta-lactamase
of
extended-spectrum
(ESBL)-producing
microorganisms.
is
found
in
the
resistomes
some
Enterobacteriaceae,
Morganellaceae,
Pasteurellaceae,
Moraxellaceae,
Aeromonadaceae,
Pseudomonadaceae,
Yersiniaceae,
and
Vibrionaceae.
Most
ESBL
detection
methods,
including
those
to
detect
OXA-1-producing
microorganisms,
are
time-consuming,
require
specialized
equipment
qualified
personnel.
Here,
we
report
a
new
CRISPR(Clustered
Regularly
Interspaced
Short
Palindromic
Repeats)/Cas12a-based
assay
coupled
with
polymerase
chain
reaction
(PCR)
sensitively
OXA-1-bearing
PCR-coupled
CRISPR/Cas12a-based
fluorescence
includes
(i)
pre-amplification
step
(ii)
nucleic
acid
step.
based
on
commonly
used
PCR,
CRISPR/Cas12a
property
nonspecifically
hydrolyze
single-stranded
DNA
fluorescent
reporter
molecules.
takes
65
min,
shortened
only
5
min.
developed
can
easily
single
(1.25)
copies
efficient
not
model
matrix
but
also
blaOXA-1-positive
We
hope
that
our
has
potential
improve
monitoring
microorganisms
therefore
contribute
mitigating
deadly
global
threat
antibiotic-resistant
Journal of Clinical Medicine,
Год журнала:
2024,
Номер
13(7), С. 2067 - 2067
Опубликована: Апрель 2, 2024
Background:
Autism
spectrum
disorder
(ASD)
is
a
complex
neurodevelopmental
condition
characterized
by
social
communication
challenges
and
repetitive
behaviors.
Recent
research
has
increasingly
focused
on
the
genetic
underpinnings
of
ASD,
with
Neurexin
1
(NRXN1)
gene
emerging
as
key
player.
This
comprehensive
systematic
review
elucidates
contribution
NRXN1
variants
in
pathophysiology
ASD.
Methods:
The
protocol
for
this
was
designed
priori
registered
PROSPERO
database
(CRD42023450418).
A
risk
bias
analysis
conducted
using
Joanna
Briggs
Institute
(JBI)
critical
appraisal
tool.
We
examined
various
studies
that
link
disruptions
discussing
both
genotypic
variability
resulting
phenotypic
expressions.
Results:
Within
review,
there
marked
heterogeneity
observed
ASD
manifestations
among
individuals
mutations.
presence
mutations
population
emphasizes
gene’s
role
synaptic
function
neural
connectivity.
Conclusion:
not
only
highlights
but
also
need
further
to
unravel
disorder.
better
knowledge
about
multifaceted
can
provide
crucial
insights
into
neurobiological
foundations
autism
pave
way
novel
therapeutic
strategies.